Evidence map›Paper›PMID 38371311›Full record

ReviewInternational journal of cardiology. Heart & vasculature2024

Comprehensive comparative efficacy and safety of potent P2Y

Chien-Lung Huang, Tien-Ping Tsao, Wei-Hsian Yin, Wen-Bin Huang, Hsu-Lung Jen, Chang-Chyi Lin, Chung-Yi Chang, Ching-Hwa Hsu

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of cardiology. Heart & vasculature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chien-Lung HuangDivision of Cardiology, Heart Center, Chen Hsin General Hospital, Taipei, Taiwan, ROC.
Tien-Ping TsaoDivision of Cardiology, Heart Center, Chen Hsin General Hospital, Taipei, Taiwan, ROC.
Wei-Hsian YinDivision of Cardiology, Heart Center, Chen Hsin General Hospital, Taipei, Taiwan, ROC.
Wen-Bin HuangDivision of Cardiology, Heart Center, Chen Hsin General Hospital, Taipei, Taiwan, ROC.
Hsu-Lung JenDivision of Cardiology, Heart Center, Chen Hsin General Hospital, Taipei, Taiwan, ROC.
Chang-Chyi LinDivision of Cardiology, Heart Center, Chen Hsin General Hospital, Taipei, Taiwan, ROC.
Chung-Yi ChangCardiovascular surgeon, Division of Cardiovascular Surgery, Heart Center, Chen Hsin General Hospital, Taipei, Taiwan, ROC.
Ching-Hwa HsuSchool of Nursing, College of Medicine, Chang Gung University, Taiwan, ROC.
Cheng Hsin General Hospital · TWChang Gung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potent P2Y

Indexed as

Coronary interventionPotent P2Y12 inhibitorRandomized control trialReal-world evidence

Identifiers

PMID38371311
PMCPMC10869917
OpenAlexW4391731004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.